We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$19.8M
Cap. Flow
+$10.3M
Cap. Flow %
4.36%
Top 10 Hldgs %
50.47%
Holding
162
New
31
Increased
16
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$13.2M
2
EWS icon
iShares MSCI Singapore ETF
EWS
+$1.69M
3
ESPR
Esperion Therapeutics
ESPR
+$1.3M
4
B
Barrick Mining
B
+$1.27M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.19M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.8M
2
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.71M
3
OGN icon
Organon & Co
OGN
+$3.01M
4
ROIV icon
Roivant Sciences
ROIV
+$868K
5
ALT icon
Altimmune
ALT
+$778K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.44%
2 Healthcare 20.32%
3 Materials 13.21%
4 Energy 8.84%
5 Technology 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
51
CALL
McDonald's
MCD
$166B
$870K 0.37%
2,800
– –
SLB icon
52
SLB Ltd
SLB
$74B
$822K 0.35%
+16,000
New +$777K
AMD icon
53
Advanced Micro Devices
AMD
$992B
$814K 0.35%
4,000
– –
UBS icon
54
UBS Group
UBS
$149B
$730K 0.31%
+19,000
New +$813K
QQQM icon
55
PUT
Invesco NASDAQ 100 ETF
QQQM
$109B
$713K 0.3%
3,000
– –
ITUB icon
56
Itaú Unibanco
ITUB
$89.2B
$691K 0.29%
82,400
– –
ARDX icon
57
Ardelyx
ARDX
$875M
$689K 0.29%
115,000
– –
SAP icon
58
CALL
SAP
SAP
$243B
$685K 0.29%
4,000
– –
BKT icon
59
BlackRock Income Trust
BKT
$309M
$674K 0.29%
63,810
– –
OSUR icon
60
OraSure Technologies
OSUR
$263M
$657K 0.28%
219,033
– –
XSD icon
61
PUT
State Street SPDR S&P Semiconductor ETF
XSD
$3.1B
$652K 0.28%
2,000
– –
KSPI icon
62
Kaspi.kz JSC
KSPI
$18.2B
$644K 0.27%
8,700
+4,000
+85% +$302K
BIIB icon
63
Biogen
BIIB
$33.6B
$642K 0.27%
3,500
– –
HAL icon
64
Halliburton
HAL
$26.3B
$624K 0.27%
16,000
+10,000
+167% +$346K
KGS icon
65
Kodiak Gas Services
KGS
$5.23B
$612K 0.26%
+10,500
New +$510K
MRK icon
66
Merck
MRK
$368B
$601K 0.26%
5,000
– –
PDS
67
Precision Drilling
PDS
$997M
$590K 0.25%
+6,000
New +$514K
DHC
68
Diversified Healthcare Trust
DHC
$1.92B
$564K 0.24%
85,000
– –
NOK icon
69
Nokia
NOK
$58B
$563K 0.24%
70,000
– –
ARIS
70
Aris Mining
ARIS
$3.66B
$557K 0.24%
30,000
– –
ICLR icon
71
Icon
ICLR
$13.1B
$553K 0.24%
5,000
+3,200
+178% +$437K
RMR icon
72
The RMR Group
RMR
$313M
$549K 0.23%
35,500
– –
PAAS icon
73
Pan American Silver
PAAS
$19.1B
$546K 0.23%
+10,000
New +$577K
LNTH icon
74
Lantheus
LNTH
$6.5B
$539K 0.23%
7,100
– –
SVM
75
Silvercorp Metals
SVM
$2.4B
$537K 0.23%
50,000
– –
1 2
3
4 5

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Pavaki Capital Management held 162 positions worth $235M, down 7.8% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $10.3M of net new capital in Q1 2026, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $8.8M trimmed.

  • Pavaki Capital Management's largest Q1 2026 buy was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
  • Pavaki Capital Management added most to Chevron in Q1 2026, an estimated $13.2M increase.
  • Pavaki Capital Management's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $8.8M.
  • Pavaki Capital Management fully exited Roivant Sciences in Q1 2026, selling an estimated $868K.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $235M portfolio in Q1 2026.
  • Pavaki Capital Management opened 31 new positions and closed 6 in Q1 2026.
  • Pavaki Capital Management's portfolio value fell 7.8% quarter-over-quarter to $235M.

Based on Pavaki Capital Management's 13F filing for Q1 2026, filed 7 Aug 2026.